Missed our webinar about generating real-world evidence to support NICE severity modifier modelling?
Watch it here!
They covered the recent update by NICE to its methods and processes for health technology assessment, which includes a number of significant changes to how innovative medicines will be evaluated for pricing and reimbursement in the UK. They also addressed how granular RWE can support demonstration of severity, including as companies seek near-term responses to the new methods.
Watch this 35-minute webinar, with a 15-minute presentation followed by Q&A.